APA

Gane E. J., Roberts S. K., Stedman C. A. M., Angus P. W., Ritchie B., Elston R., Ipe D., Morcos P. N., Baher L., Najera I., Chu T., Lopatin U., Berrey M. M., Bradford W., Laughlin M., Shulman N. S. & Smith P. F. (20101130). Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. : Lancet (London, England).

Chicago

Gane Edward J, Roberts Stuart K, Stedman Catherine A M, Angus Peter W, Ritchie Brett, Elston Rob, Ipe David, Morcos Peter N, Baher Linda, Najera Isabel, Chu Tom, Lopatin Uri, Berrey M Michelle, Bradford William, Laughlin Mark, Shulman Nancy S and Smith Patrick F. 20101130. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. : Lancet (London, England).

Harvard

Gane E. J., Roberts S. K., Stedman C. A. M., Angus P. W., Ritchie B., Elston R., Ipe D., Morcos P. N., Baher L., Najera I., Chu T., Lopatin U., Berrey M. M., Bradford W., Laughlin M., Shulman N. S. and Smith P. F. (20101130). Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. : Lancet (London, England).

MLA

Gane Edward J, Roberts Stuart K, Stedman Catherine A M, Angus Peter W, Ritchie Brett, Elston Rob, Ipe David, Morcos Peter N, Baher Linda, Najera Isabel, Chu Tom, Lopatin Uri, Berrey M Michelle, Bradford William, Laughlin Mark, Shulman Nancy S and Smith Patrick F. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. : Lancet (London, England). 20101130.